Web11 apr. 2024 · Ionis Pharmaceuticals Trading Down 1.0 % Shares of IONS opened at $36.91 on Tuesday. The firm’s 50 day simple moving average is $36.73 and its 200 day simple moving average is $39.81. The company has a market capitalization of $5.28 billion, a P/E ratio of -19.43 and a beta of 0.54. Web22 feb. 2024 · About Ionis Pharmaceuticals, Inc. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing the standards …
National Bank of Canada FI Raises Position in Ionis …
WebIonis Pharmaceuticals Inc Follow Share $37.23 After Hours: $37.23 (0.00%) 0.00 Closed: Apr 11, 7:29:48 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Crispr … WebNews Ionis Pharmaceuticals Inc. IONS. Significant News Only. 03/29/23; Press Release; New data presented at AD/PD(TM)2024 show IONIS-MAPT Rx (BIIB080) substantially … bishops caravans grimsby
AstraZeneca and Ionis sign deal to develop and commercialise …
Web1 dag geleden · Aktuelle Ionis Pharmaceuticals Inc Aktie News Relevant Alle vom Unternehmen Peer Group Sortieren: Datum Meistgelesen 23.02.23 finanzen.netIonis … Web9 jan. 2024 · NEW YORK and CARLSBAD, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc RPRX and Ionis Pharmaceuticals, Inc. IONS today announced that Royalty Pharma has acquired an interest in Ionis’ royalty in Biogen’s SPINRAZA® (nusinersen) and Novartis’ pelacarsen for up to $1.125 billion, including an upfront … Web14 apr. 2024 · Fidelity Management & Research Co has recently announced that it has increased stake in Ionis Pharmaceuticals Inc. (NASDAQ:IONS) by 0.08%. After grabbing 21.31 million shares, the institutional investor is now in possession of 16360.0 shares of the Healthcare Company. bishops caravans